NEW YORK, Aug. 14 - IBM and Physiome Sciences have entered into a non-exclusive alliance that will combine IBM's supercomputing technology with Physiome’s biological modeling software, the companies announced.  

The deal, which makes IBM Physiome's preferred IT supplier for custom computing, will allow Physiome to “speed up” its ability to simulate models of various cells, tissues and organs, and affect the behavior of certain disease states. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.